Document is current
Any future updates will be listed below
-
Authors
Shi, Huaikai
Yu, Ta-Kun
Johnson, Ben
Selvamani, Sakthi Priya
Zhuang, Ling
Lee, Kenneth
Klebe, Sonja
Smith, Samuel
Wong, Kirby
Chen, Kate
Clark, Georgina
Rath, Emma M.
Pearson, Holly
Ortega, David Gallego
Linton, Anthony
Kao, Steven
Silveira, Pablo
Cheng, Yuen Yee
-
Funding
Funding for this research was provided by:
Tour du Cure
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 2 February 2025
First Online: 12 February 2025
Declarations
:
: The experimental protocol for animal studies was reviewed and approved by the Sydney Local Health District (2019/023). Patient data from the AdvanTIG-105 trial were selected and approved by Beigene for publication.
: All authors agreed on the manuscript.
: The authors declare no potential conflicts of interest.
